Stockscreener 앱 받기
0.1118
7.37%
-0.0089
시장 영업 전:
.11
-0.0018
-1.61%
전일 마감가:
$0.1207
열려 있는:
$0.118
하루 거래량:
548.80K
Relative Volume:
0.16
시가총액:
$5.51M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.50%
1개월 성능:
-71.91%
6개월 성능:
-83.06%
1년 성능:
-93.57%
1일 변동 폭
$0.107
$0.1204
1주일 범위
$0.107
$0.1224
52주 변동 폭
$0.0961
$1.74
Cellyan Biotechnology Co Ltd Stock (HKPD) Company Profile
Compare HKPD vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HKPD
Cellyan Biotechnology Co Ltd
|
0.1118 | 5.51M | 0 | 0 | 0 | 0.00 |
MCK
Mckesson Corp
|
866.64 | 101.04B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
306.92 | 58.57B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
220.22 | 50.99B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
86.37 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.75 | 642.53M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cellyan Biotechnology Co Ltd 주식(HKPD)의 최신 뉴스
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - TipRanks
Cellyan Biotechnology Refreshes Board as Independent Director Resigns and Successor Named in September 2026 - TipRanks
Cellyan Biotechnology (NASDAQ: HKPD) Announces Extraordinary Meeting on September 21, 2026 for Share Consolidation Proposal - Kalkine Media
12 Industrials Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Cellyan Biotechnology Calls September 21 EGM to Approve 1-for-20 Share Consolidation - TipRanks
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - marketscreener.com
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - benzinga.com
12 Industrials Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Tuesday's Intraday Session - Benzinga
Cellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 ResistanceMA Cross Alert - vinanet.vn
Kam Leung Chan Net Worth (2026) - GuruFocus
Jingyan Wu Net Worth (2026) - GuruFocus
Shu Liu Net Worth (2026) - GuruFocus
Chenyu Andy Liang Net Worth (2026) - GuruFocus
Zifeng Wang Net Worth (2026) - GuruFocus
Mike Yao Zhou Net Worth (2026) - GuruFocus
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Cellyan Biotechnology Wins Second Nasdaq Grace Period to Fix Sub-$1 Share Price - TipRanks
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened - Benzinga
Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule - marketscreener.com
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance By Investing.com - Investing.com Nigeria
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's after hours session: top gainers and losers - ChartMill
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - The Manila Times
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance - Investing.com
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance - Quiver Quantitative
Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension - Stock Titan
Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11 - Stock Titan
Cellyan Biotech (HKPD) Holds Steady Near Support After Minor DeclineMA Cross Alert - dars.gov.et
12 Industrials Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] Cellyan Biotechnology Co., Ltd SEC Filing - Stock Titan
Cellyan Biotechnology (HKPD) Slides 3.78% to $0.40 as Biotech Volatility PersistsBox Spread - dars.gov.et
Cellyan Biotech (HKPD) Slides 7.6%, Testing Key Support at $0.39Channel Projection - newsline.com
Cellyan Biotechnology (NASDAQ: HKPD) files $200M shelf to sell shares, debt - Stock Titan
Cellyan Biotechnology (HKPD) director CHAN Kam Leung files initial Form 3 - Stock Titan
12 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
[Form 3] Cellyan Biotechnology Co., Ltd Initial Statement of Beneficial Ownership - Stock Titan
Cellyan Biotechnology (HKPD) Chief Strategy Officer listed with no Form 3 transactions - Stock Titan
Cellyan Biotechnology (HKPD) CFO Liu Shu files initial ownership Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) director Zhou Mike Yao files initial Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) director Wu Jingyan submits initial SEC Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) CEO and director files Form 3 with no share transactions - Stock Titan
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - Yahoo Finance
Cellyan Biotechnology (HKPD) Slumps 7.83%: Key Support at $0.50 Under PressureFibonacci Fan - The Legal Advocate
Cellyan Biotechnology (HKPD) Holds Steady Near Support After Marginal GainsAdvance Decline Volume - The Legal Advocate
HKPDCellyan Biotechnology Co Ltd Stock Price and Quote - Finviz
Cellyan Biotechnology (HKPD) Drops 3.6% as Shares Approach Critical $0.50 SupportButterfly Setup - The Legal Advocate
Cellyan Biotechnology Faces Resistance at $0.57 After Recent DeclineSeasonality Effect - po-news-eg.net
Cellyan Biotechnology Co Ltd (HKPD) 재무 분석
Cellyan Biotechnology Co Ltd (HKPD)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.28%
7.50%
자본화:
|
볼륨(24시간):